4Calvo P,Alonso MJ,Vila-Jato JL. Improved ocular bioavailability of indomethacin by novel ocular drug carriers[J].Journal of Pharmacy and Pharmacology,1996.1147-1152.
5Shen Y,Tu J. Preparation and ocular pharmacokinetics of ganciclovir liposomes[J].J AAPS,2007.E371-E377.
6Law SL,Huang KJ,Chiang CH. Acyclovir-containing liposomes for potential ocular delivery Corneal penetration and absorption[J].Journal of Controlled Release,2000.135-140.
7Hosny KM. Optimization of gatifloxacin liposomal hydrogel for enhanced transcorneal permeation[J].Journal of Liposome Research,2010.31-37.
8Aggarwal D,Kaur IP. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system[J].International Journal of Pharmaceutics,2005.155-159.
9Kapoor Y,Chauhan A. Ophthalmic delivery of Cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels[J].International Journal of Pharmaceutics,2008.222-229.
10Benita S,Levy MY. Submicron emulsions as colloidal drug carriers for intravenous administration:comprehensive physicochemical characterization[J].Journal of Pharmaceutical Sciences,1993.1069-1079.
